Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027 Life Science Investing
RenovoRx CEO Shaun Bagai to Present at the Alliance Global Partners Emerging AgBiotech/Bio-Solutions Virtual Showcase on November 20th Life Science Investing
Harmony Biosciences Announces Initiation of First-In-Human Study With Potential Best-In-Class Orexin 2 Receptor Agonist for Central Disorders of Hypersomnolence Life Science Investing
Quantum-Si to Highlight Significant Proteus Platform Development Progress and Provide Insights into the Company's Industry Leading Technology Pipeline at Investor & Analyst Day Life Science Investing
Anavex Life Sciences to Present at the 44TH ANNUAL J.P. MORGAN Healthcare Conference Life Science Investing
Arrowhead Pharmaceuticals Announces FDA Approval of REDEMPLO® to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome Life Science Investing
Rain Enhancement Technologies Secures Second U.S. Installation with Utah Permit Approval, Advances Snow Enhancement Capabilities Life Science Investing
Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting Life Science Investing
